BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 33515595)

  • 1. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
    Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
    Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
    Fish R; Sanders C; Williamson PR; Renehan AG
    BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
    Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
    Trials; 2020 May; 21(1):437. PubMed ID: 32460828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.
    Byrne M; O'Connell A; Egan AM; Dinneen SF; Hynes L; O'Hara MC; Holt RIG; Willaing I; Vallis M; Hendrieckx C; Coyne I
    Trials; 2017 Dec; 18(1):602. PubMed ID: 29258565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of core outcome sets of Food for Special Medical Purposes designed for type 2 diabetes mellitus: a study protocol.
    Mu D; Gong J; Wei Y; Chen M; Yu J; Du L; Hu W
    Trials; 2023 Mar; 24(1):223. PubMed ID: 36959627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a core outcome set and outcome measurement set for physiotherapy trials in adults with Bronchiectasis (COS-PHyBE study): A protocol.
    Hamzeh H; Spencer S; Kelly C
    PLoS One; 2022; 17(2):e0263695. PubMed ID: 35134099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
    Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
    Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome.
    Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core Health Outcomes in Childhood Epilepsy (CHOICE): Development of a core outcome set using systematic review methods and a Delphi survey consensus.
    Crudgington H; Rogers M; Bray L; Carter B; Currier J; Dunkley C; Gibbon FM; Hughes D; Lyle S; Roberts D; Tudur Smith C; Gringras P; Pal DK; Morris C
    Epilepsia; 2019 May; 60(5):857-871. PubMed ID: 31021436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important research outcomes for treatment studies of perinatal depression: systematic overview and development of a core outcome set.
    Hellberg C; Österberg M; Jonsson AK; Fundell S; Trönnberg F; Jonsson M; Skalkidou A
    BJOG; 2021 Dec; 128(13):2141-2149. PubMed ID: 34047454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes.
    Millar AN; Daffu-O'Reilly A; Hughes CM; Alldred DP; Barton G; Bond CM; Desborough JA; Myint PK; Holland R; Poland FM; Wright D;
    Trials; 2017 Apr; 18(1):175. PubMed ID: 28403876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a core outcome set for research and audit studies in reconstructive breast surgery.
    Potter S; Holcombe C; Ward JA; Blazeby JM;
    Br J Surg; 2015 Oct; 102(11):1360-71. PubMed ID: 26179938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determine what to measure and how to measure in clinical trials for the treatment of pressure injury: A protocol for the development of a core outcome set.
    Shi J; Gao Y; Si L; Ma X; Liu M; Liao X; Zhang J
    Medicine (Baltimore); 2020 Feb; 99(9):e19311. PubMed ID: 32118756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults.
    Duane S; Vellinga A; Murphy AW; Cormican M; Smyth A; Healy P; Moore M; Little P; Devane D
    Trials; 2019 Feb; 20(1):106. PubMed ID: 30732617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core Outcome Set-STAndards for Development: The COS-STAD recommendations.
    Kirkham JJ; Davis K; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR
    PLoS Med; 2017 Nov; 14(11):e1002447. PubMed ID: 29145404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.